Myrtelle

New York, NY · Founded 2020 · Privately Held (backing)

Operator of a gene therapy company intended to offer innovative clinical trials for the treatment of the rare monogenic disorder. Myrtelle is based in New York, NY and was founded in 2020. Its last reported valuation was $134 million in Dec 2022. It has raised $82.6 million across 4 recorded rounds; the latest was a $30.5 million early-stage round in Dec 2025.

Last reported valuation
$134.0M
Oct 2026
Priced at
—
Total raised
$82.6M
Last round
Early Stage VC
Dec 2025
What is Myrtelle worth?
$134.0Mlast reported valuation · Oct 2026

Myrtelle's last reported valuation, Dec 2022. Nothing priced has surfaced since.

Free account
More of Myrtelle with a free account
  • ·Watch Myrtelle: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Myrtelle funding history

4 rounds
DateRoundRaisedPost-money
Dec 2025Early Stage VC$30.5M▮
Mar 2025Debt$7.5M▮
May 2024Debt$6.0M▮
Apr 2021Early Stage VC$13.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Myrtelle valuation

Myrtelle's last reported valuation was $134 million in Dec 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Myrtelle raised?

Myrtelle has raised $82.6 million across 4 recorded rounds since 2021. The largest was a $7.5 million debt round in Mar 2025; the most recent was a $30.5 million early-stage round in Dec 2025.

Myrtelle has filed 4 Form Ds with the SEC since 2021, most recently in Mar 2025 ($7.5 million sold to 1 investor).

How Myrtelle's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Myrtelle, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Myrtelle

What is Myrtelle worth?
Myrtelle is valued at $134.0M as of Oct 2026. Myrtelle's last reported valuation, Dec 2022. Nothing priced has surfaced since.
How much has Myrtelle raised?
Myrtelle has raised $82.6M in total funding across 4 recorded rounds.
When did Myrtelle last raise?
Myrtelle last raised in Dec 2025 (Early Stage VC), raising $30.5M.